CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 57.14%

Compliant submissions 4

Incompliant submissions 3

Total trials 7

My Organizations' Clinical Trials

Showing 300 of 357 entries

View as:

Genetic Aspects of Neurologic and Psychiatric Disorders

Phase: N/A Priority: Normal

NCT ID: NCT00001544 Org: User:

Start: 04/30/96 End: 03/31/04 Due: 03/31/05

Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT04339790 Org: User:

Start: 04/07/20 End: 06/02/21 Due: 06/02/22

PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of McCune-Albright Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT02743377 Org: User:

Start: 04/04/18 End: 05/19/20 Due: 05/19/21

Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression

Phase: N/A Priority: Normal

NCT ID: NCT00532103 Org: User:

Start: 07/31/07 End: 02/29/08 Due: 02/28/09

Spatial Context and Fear Learning

Phase: N/A Priority: Normal

NCT ID: NCT02423044 Org: User:

Start: 04/18/15 End: 10/30/18 Due: 10/30/19

PET Imaging of Cyclooxygenase in Multiple Sclerosis

Phase: N/A Priority: Normal

NCT ID: NCT05062083 Org: User:

Start: 06/07/22 End: 01/30/24 Due: 01/30/25

Neuropsychiatric Effects of Interferon-Alpha and Ribavirin

Phase: N/A Priority: Normal

NCT ID: NCT00001547 Org: User:

Start: 06/30/96 End: 06/30/02 Due: 06/30/03

Serotonin Transporters in Alcoholism

Phase: N/A Priority: Normal

NCT ID: NCT00085865 Org: User:

Start: 06/30/04 End: 07/31/06 Due: 07/31/07

Examination of Brain Serotonin Receptors in Patients With Mood Disorders

Phase: N/A Priority: Normal

NCT ID: NCT00026832 Org: User:

Start: 10/04/01 End: 11/27/12 Due: 11/27/13

Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study

Phase: N/A Priority: Normal

NCT ID: NCT00105274 Org: User:

Start: 03/07/05 End: 02/02/10 Due: 02/02/11

Clinical Trial of Memantine for Major Depression

Phase: N/A Priority: Normal

NCT ID: NCT00040261 Org: User:

Start: 06/30/02 End: 03/31/05 Due: 03/31/06

Clinical Trial of Pramipexole in Bipolar Depression

Phase: N/A Priority: Normal

NCT ID: NCT00025792 Org: User:

Start: 10/31/01 End: 11/30/05 Due: 11/30/06

A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation

Phase: N/A Priority: Normal

NCT ID: NCT00794040 Org: User:

Start: 11/17/08 End: 02/01/18 Due: 02/01/19

Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders

Phase: N/A Priority: Normal

NCT ID: NCT00251303 Org: User:

Start: 08/31/05 End: 02/29/12 Due: 02/28/13

Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder

Phase: N/A Priority: Normal

NCT ID: NCT00327756 Org: User:

Start: 05/31/06 End: - Due: -

Brain Function in Mentally Ill Adolescents

Phase: N/A Priority: Normal

NCT ID: NCT00025857 Org: User:

Start: 10/22/01 End: 06/29/12 Due: 06/29/13

PET Imaging of Peripheral Benzodiazepine Receptors

Phase: N/A Priority: Normal

NCT ID: NCT00696371 Org: User:

Start: 06/06/08 End: 08/19/14 Due: 08/19/15

Fear Conditioning Using Computer-Generated Virtual Reality

Phase: N/A Priority: Normal

NCT ID: NCT00025844 Org: User:

Start: 10/22/01 End: 04/10/12 Due: 04/10/13

Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar Illness

Phase: N/A Priority: Normal

NCT ID: NCT00015769 Org: User:

Start: 04/30/01 End: 04/30/03 Due: 04/30/04

Effects of an ER Beta Agonist (Lilly Compound LY500307) on Estradiol-Withdrawal-Induced Mood Symptoms in Women With Past Perimenopausal Depression

Phase: N/A Priority: Normal

NCT ID: NCT03689543 Org: User:

Start: 05/23/19 End: 09/09/24 Due: 09/09/25

The Antidepressant Efficacy of the Anticholinergic Scopolamine

Phase: N/A Priority: Normal

NCT ID: NCT00369915 Org: User:

Start: 08/31/06 End: 01/31/13 Due: 01/31/14

Clinical Trial of Estrogen for Postpartum Depression

Phase: N/A Priority: Normal

NCT ID: NCT00059228 Org: User:

Start: 04/17/03 End: 11/15/16 Due: 11/15/17

Psychological Mechanisms of Behavioral Dysregulation

Phase: N/A Priority: Normal

NCT ID: NCT00352456 Org: User:

Start: 08/27/04 End: 04/21/08 Due: 04/21/09

Hormonal Causes of Menstrual-Related Mood Disorders

Phase: N/A Priority: Normal

NCT ID: NCT00100360 Org: User:

Start: 12/22/04 End: 12/15/16 Due: 12/15/17

Treatment for Adolescents With Depression Study (TADS)

Phase: N/A Priority: Normal

NCT ID: NCT00006286 Org: User:

Start: 09/30/98 End: 03/31/04 Due: 03/31/05

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Genetic Aspects of Neurologic and Psychiatric Disorders	NCT00001544	National Institute of Mental Health (NIMH)	user2@example.com	None	1996-04-30	2004-03-31	2005-03-31	-	-	2025-07-14
Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers	NCT04339790	National Institute of Mental Health (NIMH)	user2@example.com	None	2020-04-07	2021-06-02	2022-06-02	-	-	2025-07-14
PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of McCune-Albright Syndrome	NCT02743377	National Institute of Mental Health (NIMH)	user2@example.com	None	2018-04-04	2020-05-19	2021-05-19	-	-	2025-07-14
Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression	NCT00532103	National Institute of Mental Health (NIMH)	user2@example.com	None	2007-07-31	2008-02-29	2009-02-28	-	-	2025-07-14
Spatial Context and Fear Learning	NCT02423044	National Institute of Mental Health (NIMH)	user2@example.com	None	2015-04-18	2018-10-30	2019-10-30	-	-	2025-07-14
PET Imaging of Cyclooxygenase in Multiple Sclerosis	NCT05062083	National Institute of Mental Health (NIMH)	user2@example.com	None	2022-06-07	2024-01-30	2025-01-30	-	-	2025-07-14
Neuropsychiatric Effects of Interferon-Alpha and Ribavirin	NCT00001547	National Institute of Mental Health (NIMH)	user2@example.com	None	1996-06-30	2002-06-30	2003-06-30	-	-	2025-07-14
Serotonin Transporters in Alcoholism	NCT00085865	National Institute of Mental Health (NIMH)	user2@example.com	None	2004-06-30	2006-07-31	2007-07-31	-	-	2025-07-14
Examination of Brain Serotonin Receptors in Patients With Mood Disorders	NCT00026832	National Institute of Mental Health (NIMH)	user2@example.com	None	2001-10-04	2012-11-27	2013-11-27	-	-	2025-07-14
Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study	NCT00105274	National Institute of Mental Health (NIMH)	user2@example.com	None	2005-03-07	2010-02-02	2011-02-02	-	-	2025-07-14
Clinical Trial of Memantine for Major Depression	NCT00040261	National Institute of Mental Health (NIMH)	user2@example.com	None	2002-06-30	2005-03-31	2006-03-31	-	-	2025-07-14
Clinical Trial of Pramipexole in Bipolar Depression	NCT00025792	National Institute of Mental Health (NIMH)	user2@example.com	None	2001-10-31	2005-11-30	2006-11-30	-	-	2025-07-14
A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation	NCT00794040	National Institute of Mental Health (NIMH)	user2@example.com	None	2008-11-17	2018-02-01	2019-02-01	-	-	2025-07-14
Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders	NCT00251303	National Institute of Mental Health (NIMH)	user2@example.com	None	2005-08-31	2012-02-29	2013-02-28	-	-	2025-07-14
Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder	NCT00327756	National Institute of Mental Health (NIMH)	user2@example.com	None	2006-05-31	-	-	-	-	2025-07-14
Brain Function in Mentally Ill Adolescents	NCT00025857	National Institute of Mental Health (NIMH)	user2@example.com	None	2001-10-22	2012-06-29	2013-06-29	-	-	2025-07-14
PET Imaging of Peripheral Benzodiazepine Receptors	NCT00696371	National Institute of Mental Health (NIMH)	user2@example.com	None	2008-06-06	2014-08-19	2015-08-19	-	-	2025-07-14
Fear Conditioning Using Computer-Generated Virtual Reality	NCT00025844	National Institute of Mental Health (NIMH)	user2@example.com	None	2001-10-22	2012-04-10	2013-04-10	-	-	2025-07-14
Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar Illness	NCT00015769	National Institute of Mental Health (NIMH)	user2@example.com	None	2001-04-30	2003-04-30	2004-04-30	-	-	2025-07-14
Effects of an ER Beta Agonist (Lilly Compound LY500307) on Estradiol-Withdrawal-Induced Mood Symptoms in Women With Past Perimenopausal Depression	NCT03689543	National Institute of Mental Health (NIMH)	user2@example.com	None	2019-05-23	2024-09-09	2025-09-09	-	-	2025-07-14
The Antidepressant Efficacy of the Anticholinergic Scopolamine	NCT00369915	National Institute of Mental Health (NIMH)	user2@example.com	None	2006-08-31	2013-01-31	2014-01-31	-	-	2025-07-14
Clinical Trial of Estrogen for Postpartum Depression	NCT00059228	National Institute of Mental Health (NIMH)	user2@example.com	None	2003-04-17	2016-11-15	2017-11-15	-	-	2025-07-14
Psychological Mechanisms of Behavioral Dysregulation	NCT00352456	National Institute of Mental Health (NIMH)	user2@example.com	None	2004-08-27	2008-04-21	2009-04-21	-	-	2025-07-14
Hormonal Causes of Menstrual-Related Mood Disorders	NCT00100360	National Institute of Mental Health (NIMH)	user2@example.com	None	2004-12-22	2016-12-15	2017-12-15	-	-	2025-07-14
Treatment for Adolescents With Depression Study (TADS)	NCT00006286	National Institute of Mental Health (NIMH)	user2@example.com	None	1998-09-30	2004-03-31	2005-03-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance